Pacer Advisors
ISEE

Pacer Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Pacer Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,528
Closed -$22K – 1588
2021
Q1 		$22K Sell
3,528
-736
-17% -$4.47K ﹤0.01% 1502
2020
Q4 		$29K Buy
+4,264
New +$27.3K ﹤0.01% 1466

Other funds holding ISEE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Pacer Advisors's ISEE Position: Q2 2021 in Review

Pacer Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2021, closing a stake of 3,528 shares — an estimated $22K sold.

Pacer Advisors first reported a position in ISEE in Q4 2020 and held it in 2 quarters. The position peaked at $29K in Q4 2020. 128 funds tracked by Wall St. Rank hold ISEE as of Q2 2021.

  • Pacer Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 3,528 IVERIC bio, Inc. Common Stock shares in Q2 2021, an estimated $22K.
  • Pacer Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Pacer Advisors's IVERIC bio, Inc. Common Stock position peaked at $29K in Q4 2020.
  • 128 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.